Tristel PLC · LSE:TSTL

Tristel — Investor Presentation (July 2016)

12 slides from Tristel's investor presentation, Jul 21, 2016

  1. Slide 1: Shareholder Open Day

    SHAREHOLDER OPEN DAY 21 JULY 2016 CHAIRMAN: FRANCISCO SOLER CHIEF EXECUTIVE: PAUL SWINNEY FINANCE DIRECTOR: LIZ DIXON

  2. Slide 2: Revenue compound annual growth rate over 11 years: 17%

    REVENUE COMPOUND ANNUAL GROWTH RATE OVER 11 YEARS: 17% £ MILLIONS 17.0 15.3 13.5 10.9 9.3 10.6 8.8 6.9 6.0 5.1 3.8 3.0 2004-2005 2005-2006 2006-2007 2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 2012-2013 2013-2014 2014-2015 2015-2016 Page 1

  3. Slide 3: Revenue by Portfolio

    REVENUE BY PORTFOLIO £ MILLIONS 14.5 Human Healthcare Contamination Control 13.1 Animal Healthcare 11.5 8.9 1.5 1.4 1.2 1.0 0.9 0.8 0.8 0.8 2012-2013 2013-2014 2014-2015 2015-2016 Page 2

  4. Slide 4: Global Hospital Revenue

    GLOBAL HOSPITAL REVENUE £ MILLIONS Instruments Surfaces Other 2.0 1.4 11.1 Page 3

  5. Slide 5: Sales by Geography

    SALES BY GEOGRAPHY £ MILLIONS UK Overseas 10.4 9.8 9.0 7.3 39% 36% 6.6 33% 5.5 31% 4.5 3.3 2012-2013 2013-2014 2014-2015 2015-2016 Page 4

  6. Slide 6: Group Ophthalmology Revenue

    GROUP OPHTHALMOLOGY REVENUE £203,000 TONOMETER PRISM* £146,000 £65,000 2013-2014 2014-2015 2015-2016 *http://www.haag-streit-fareast.com/uploads/RTEmagicC_Selector_Prisms_26.jpg.jpg Page 5

  7. Slide 7: Profit Before Tax (Before Share Based Payments)

    PROFIT BEFORE TAX (BEFORE SHARE BASED PAYMENTS) £ MILLIONS 3.1 2.6 1.8 0.5 2012-2013 2013-2014 2014-2015 2015-2016 Page 6

  8. Slide 8: Average Market Capitalisation

    AVERAGE MARKET CAPITALISATION £ MILLIONS 48.5 32.6 24.4 11.7 2012-2013 2013-2014 2014-2015 2015-2016 Page 7

  9. Slide 9: Tristel Share Price vs AIM Index

    TRISTEL SHARE PRICE VS AIM INDEX Tristel AIM Rebased 1ST JULY 2011 1ST JULY 2012 1ST JULY 2013 1ST JULY 2014 1ST JULY 2015 1ST JULY 2016 Page 8

  10. Slide 10: Australian Acquisition

    AUSTRALIAN ACQUISITION TGA Regulatory approval gained by Tristel for Tristel Wipes System in May 2011 Appointment of exclusive distributor for Australia in 2011 Previous success in building and selling distributorships in Australia in neurology, orthopaedics and urology Focus on ultrasound and ENT 2

  11. Slide 11: Dividend Per Share

    DIVIDEND PER SHARE Special Dividend Per Share Analyst’s Forecast Dividend Per Share Normal Dividend Per Share 3.00p 3.00p 3.11p 2.72p 2.85p 1.62p 0.40p 2012-2013 2013-2014 2014-2015 2015-2016 2016-2017 Page 10

  12. Slide 12: Year-End Cash

    YEAR-END CASH £ MILLIONS 5.7 4.1 2.7 0.6 2012-2013 2013-2014 2014-2015 2015-2016 Page 11

Tristel — Investor Presentation (July 2016) on 6ix